A Trial Investigating the Pharmacokinetic Properties of NN5401 in Children, Adolescents and Adults With Type 1 Diabetes.
Phase of Trial: Phase I
Latest Information Update: 14 Feb 2017
At a glance
- Drugs Insulin degludec/insulin aspart (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 16 Nov 2010 Actual end date ( Nov 2010) added as reported by ClinicalTrials.gov.
- 16 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Oct 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.